Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma - PubMed (original) (raw)

Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma

B I Dalal et al. Am J Pathol. 1993 Aug.

Abstract

The level of expression and localization of transforming growth factor-beta 1 (TGF-beta 1) were analyzed by immunocytochemistry using antibodies that distinguished the sites of intracellular synthesis and extracellular secretion of TGF-beta 1 in 28 cases of infiltrating duct carcinoma of breast, 12 of which had lymph node metastases. Twenty-seven of 28 primary tumors and all 12 lymph node metastases showed extracellular deposition of TGF-beta 1. The extracellular TGF-beta 1 staining was either confined to or more strongly expressed at the advancing edges of the tumor than in the center of the primary tumor. By contrast, 19 of 28 primary tumors and 11 of 12 metastases contained intracellular TGF-beta 1, and no variation in the intensity was seen. The metastatic tumors were significantly more intensely stained for both intra- and extracellular TGF-beta 1 than the primary tumor tissues. The preferential expression of secreted TGF-beta 1 at the advancing tumor edges and in lymph node metastases suggests a role for TGF-beta 1 in the malignant progression of breast carcinoma.

PubMed Disclaimer

Cited by

The type III TGF-beta receptor suppresses breast cancer progression.
Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR, Blobe GC. Dong M, et al. J Clin Invest. 2007 Jan;117(1):206-17. doi: 10.1172/JCI29293. Epub 2006 Dec 7. J Clin Invest. 2007. PMID: 17160136 Free PMC article.
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL. Kong FM, et al. Ann Surg. 1995 Aug;222(2):155-62. doi: 10.1097/00000658-199508000-00007. Ann Surg. 1995. PMID: 7543740 Free PMC article.
Inflammation and tumor microenvironment.
Niu T, Zhou F. Niu T, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Dec 28;48(12):1899-1913. doi: 10.11817/j.issn.1672-7347.2023.230231. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38448384 Free PMC article. Review. Chinese, English.
TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
Huang SC, Wei PC, Hwang-Verslues WW, Kuo WH, Jeng YM, Hu CM, Shew JY, Huang CS, Chang KJ, Lee EY, Lee WH. Huang SC, et al. EMBO Mol Med. 2017 Dec;9(12):1660-1680. doi: 10.15252/emmm.201606914. EMBO Mol Med. 2017. PMID: 28993429 Free PMC article.
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis.
Papageorgis P. Papageorgis P. J Oncol. 2015;2015:587193. doi: 10.1155/2015/587193. Epub 2015 Mar 25. J Oncol. 2015. PMID: 25883652 Free PMC article. Review.

References

1. J Biol Chem. 1987 May 15;262(14):6443-6 - PubMed
1. Science. 1987 Jul 17;237(4812):291-3 - PubMed
1. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5600-4 - PubMed
1. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6020-4 - PubMed
1. EMBO J. 1987 Jul;6(7):1899-904 - PubMed

Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma - PubMed (original) (raw)